Search results
Results from the WOW.Com Content Network
The Biomedical Advanced Research and Development Authority (BARDA) is a U.S. Department of Health and Human Services (HHS) office responsible for the procurement and development of medical countermeasures, principally against bioterrorism, including chemical, biological, radiological and nuclear (CBRN) threats, as well as pandemic influenza and emerging diseases.
Joint Program Executive Office for Chemical, Biological, Radiological and Nuclear Defense (JPEO-CBRND) [1] is a sub-office of the ASA(ALT).. The Joint Program Executive Office for Chemical, Biological, Radiological and Nuclear Defense is the Joint Service’s lead for development, acquisition, fielding and life-cycle support of chemical, biological, radiological and nuclear defense equipment ...
As a critical national asset in the CB defense community, CBC supports all phases of the acquisition life-cycle ― from basic and applied research through technology development, engineering design, equipment evaluation, product support, sustainment, field operations and demilitarization ― to address its customers’ unique requirements.
Meanwhile, the average defense stock today has an EV/S of 2.2 and a P/S of 1.8. Compared to others in the industry, Leidos' stock looks relatively cheap. Leidos also looks attractive when ...
Stock market news live updates: Stocks slide to lowest since March 2021, S&P closes below 4,000. Emily McCormick. May 9, 2022 at 4:07 PM. U.S. stocks slid Monday to extend last week's losses, as ...
Stocks shook off a choppy start to finish higher Monday, as Wall Street kicked off a holiday-shortened week. The S&P 500 ended 0.7% higher after having been down 0.5% in the early going. The Dow ...
Assistant Secretary of Defense (Nuclear, Chemical & Biological Defense Programs) Andrew C. Weber: January 7, 2011 – October 1, 2014: Robert M. Gates Leon Panetta Chuck Hagel: Barack Obama: Dr. A Thomas Hopkins (Acting) October 1, 2014 – November 29, 2017 Ash Carter: Barack Obama: Guy B. Roberts: November 30, 2017 – April 2, 2019: Jim ...
Ology Bioservices (previously named Nanotherapeutics, Inc.) is a private, American biopharmaceutical company headquartered in Alachua, Florida.The company was founded with research in nanometer-scale particle technology to develop new drug delivery technologies and increase the efficacy of existing drugs. [3]